Company Overview and News

0
Govt more interested in an Asean-wide bourse linkage

2018-07-21 malaymail
KUALA LUMPUR, July 21 — The recommendation to link Bursa Malaysia and the Singapore Exchange (SGX) needs to be studied, as the government is more interested in an Association of Southeast Asian Nations (Asean) Connect concept.
SPXCY SPXCF BSMAF S68 1818

0
The Edge Singapore wins 'Story of the Year' from inaugural SGX Orb Awards

2018-07-20 theedgemarkets
SINGAPORE (July 19): The Edge Singapore is honoured to have won one out of six categories of the inaugural SGX Orb Awards, organised by the Singapore Exchange (SGX) to recognise excellence in financial journalism and content.
SPXCY SPXCF S68

0
Koufu serves up lukewarm trading debut after giving up gains to end flat at IPO price

2018-07-18 channelnewsasia
Shares of the food court operator ended their first day of trading at the IPO price of S$0.63 each.
SPXCY SPXCF S68

0
Koufu opens above IPO price on SGX trading debut

2018-07-18 channelnewsasia
SINGAPORE: Home-grown food court operator Koufu on Wednesday (Jul 17) made its trading debut on the Singapore Exchange’s mainboard at an opening price of S$0.65.
SPXCY SPXCF S68

0
Koufu says public offering 17 times subscribed

2018-07-17 theedgemarkets
SINGAPORE (July 17): Koufu Group, one of the largest operators of food courts and coffee shops in Singapore, says the public offering was about 17 times subscribed.
SPXCY SPXCF S68

0
DLF Holdings aims to raise S$4.3m from Catalist IPO at 23 cents per share

2018-07-17 theedgemarkets
SINGAPORE (July 17): Mechanical and electrical (M&E) engineering services provider DLF Holdings has registered its offer document with the Singapore Exchange (SGX) for its initial public offering (IPO) on the Catalist board.
SPXCY SPXCF S68

0
Boardroom Ltd to buy peer Symphony House units for RM164.1m

2018-07-16 theedgemarkets
MAINBOARD-LISTED corporate services provider Boardroom plans to buy subsidiaries of a Malaysian company in the same line of business.
SPXCY SPXCF S68

0
Koufu launches IPO at 63 cents per share to raise S$74m

2018-07-12 theedgemarkets
SINGAPORE (July 11): F&B operator Koufu Group has launched its initial public offering (IPO) at 63 cents a share to raise gross proceeds of S$74.3 million with its proposed listing on the Mainboard of the Singapore Exchange (SGX).
SPXCY SPXCF S68

0
Asiatravel calls for trading suspension amid doubts over ability to continue as going concern

2018-07-09 theedgemarkets
SINGAPORE (July 9): Asiatravel.com Holdings has called for the trading of its shares on the Singapore Exchange (SGX) to be suspended with immediate effect.
SPXCY SPXCF S68

0
Hyflux granted deadline extensions for filing of 2Q and 3Q results

2018-07-09 theedgemarkets
SINGAPORE (July 9): Hyflux has been granted a six-month and three-month extension of deadlines to file its 2Q18 and 3Q18 unaudited financial statements, originally due Aug 14 and Nov 14 this year, respectively.
SPXCY SPXCF S68

0
NSE and SGX Nifty dispute: Uncertainty for investors in India markets

2018-07-05 cnbc
A dispute between stock exchanges in India and Singapore has cast doubts on a popular investment product, and it has raised questions about the future of India’s more than $2 trillion equity market.
SPXCY ALNSE SPXCF S68

5
NSE inks pact with Nasdaq for post-trade tech

2018-07-02 moneycontrol
The National Stock Exchange (NSE) today signed a technology pact with the American tech bourse Nasdaq to source technology for offering customised real-time clearing, risk management and settlements.
SPXCY SPXCF S68

15
NSE inks pact with Nasdaq for offering real-time clearing, settlements

2018-07-02 thehindubusinessline
The National Stock Exchange (NSE) has signed a technology pact with the American tech bourse Nasdaq to source technology for offering customised real-time clearing, risk management and settlements. The agreement will executed over the next 24 to 36 months.
SPXCY 500470 500116 TTST TATASTEEL SPXCF TATLY IDBI S68

11
MAHB, Sapura Energy, MBM, Parkson and Green Packet

2018-06-29 theedgemarkets
KUALA LUMPUR (June 29): Based on corporate announcements and news flow today, stocks in focus for Monday (July 2) may include the following: Malaysia Airports Holdings Bhd, Sapura Energy Bhd, MBM Resources Bhd, Parkson Holdings Bhd and Green Packet Bhd.
O9E SPXCF PMOIF 0082 PMO 5983 5014 S68 5657 SPXCY MYPRY BSMAF PMOIY 1818

9
Parkson names Chang Chae Young as CEO of Indochina operations

2018-06-29 theedgemarkets
KUALA LUMPUR (June 29): Parkson Holdings Bhd's 67.96%-owned subsidiary Parkson Retail Asia Limited, which is listed on the Singapore Exchange, has appointed Chang Chae Young as the chief executive officer (CEO) for its newly-formed Indochina Operations.
5657 O9E SPXCY SPXCF BSMAF S68 1818

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...